Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 12, 2019

SELL
$3.6 - $4.78 $180,000 - $239,000
-50,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$2.62 - $4.44 $131,000 - $222,000
50,000 New
50,000 $210,000
Q4 2018

Feb 06, 2019

SELL
$2.28 - $7.15 $22,799 - $71,500
-10,000 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$3.85 - $7.35 $46,200 - $88,200
-12,000 Reduced 54.55%
10,000 $73,000
Q2 2018

Aug 07, 2018

BUY
$3.7 - $5.65 $81,400 - $124,300
22,000 New
22,000 $81,000

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.